Sensitizing and Protective Substances in Radiation Therapy and Predictive Assays

Authors

  • Björn Zackrisson From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden
  • Elisabeth Kjellén From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden
  • Bengt Glimelius From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden
  • Jörgen Carlsson From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden
  • Bo Littbrand From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden
  • Ingela Turesson From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden

DOI:

https://doi.org/10.1080/028418602321028210

Abstract

In an investigation by the Swedish Cancer Society, an expert group described the present status, critical issues and future aspects and potentials for each of nine major areas of radiation therapy research. The present report deals with the use of sensitizing and protective substances in radiation therapy and predictive assays on normal tissues and tumour response.

Downloads

Download data is not yet available.

Downloads

Published

2002-01-01

How to Cite

Zackrisson, B., Kjellén, E., Glimelius, B., Carlsson, J., Littbrand, B., & Turesson, I. (2002). Sensitizing and Protective Substances in Radiation Therapy and Predictive Assays. Acta Oncologica, 41(7-8), 615–622. https://doi.org/10.1080/028418602321028210

Issue

Vol. 41 No. 7-8 (2002): Acta Oncologica

Section

Articles